Results 161 to 170 of about 14,903 (246)

First-in-Human Study of [²¹¹At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial). [PDF]

J Nucl Med
Watabe T, Mukai K, Naka S, Sasaki H, Kamiya T, Hayakawa T, Fukuhara A, Takano T, Shirakami Y, Ooe K, Shigeno S, Okamura S, Masumura K, Hida E, Haba H, Toyoshima A, Isohashi K, Shimomura I, Tomiyama N.   +18 more
europepmc   +1 more source

Nomogram for survival prediction in metastatic differentiated thyroid cancer and survival comparison between systemic chemotherapy and local radiotherapy in high-risk patients. [PDF]

World J Surg Oncol
Xu J.
europepmc   +1 more source

Camrelizumab and apatinib in Chinese patients with locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer: an exploratory open-label, single-arm trial. [PDF]

BMC Med
Zhang X, Sun D, Zhang Y, Mu Z, Shi C, Sun Y, Cheng X, Meng C, Wei X, Liang J, Lin Y.   +10 more
europepmc   +1 more source

The use of radiopharmaceuticals in targeted cancer therapy: a narrative review. [PDF]

Int J Physiol Pathophysiol Pharmacol
Khalaji A, Rostampour M, Riahi F, Rafieezadeh D, Dormiani Tabatabaei SA, Fesharaki S, Tooyserkani SH.   +6 more
europepmc   +1 more source

Radioactive Iodine Therapy for Pediatric Graves' Hyperthyroidism. [PDF]

Med Sci Monit
Hu RT, Li B.
europepmc   +1 more source

Predictors of Complete Remission in Differentiated Thyroid Cancer: A Study from the Nuclear Medicine Department of Ibn Rochd Hospital in Casablanca, Morocco. [PDF]

Ethiop J Health Sci
Tabiti H, Bendahhou K, Guensi A.
europepmc   +1 more source

Predictive factors for the efficacy of radioiodine therapy in patients with Graves' disease. [PDF]

Nucl Med Commun
Iwanaga H, Fujita N, Abe S, Ito R, Abe Y, Minamimoto R, Nishii R, Naganawa S, Kato K.   +8 more
europepmc   +1 more source

Microbial Transformation of Iodine: From Radioisotopes to Iodine Deficiency

, 2017
Iodine is a biophilic element that is important for human health, both as an essential component of several thyroid hormones and, on the other hand, as a potential carcinogen in the form of radioiodine generated by anthropogenic nuclear activity. Iodine exists in multiple oxidation states (-1, 0, +1, +3, +5, and +7), primarily as molecular iodine (I2),
Chris M, Yeager, Seigo, Amachi, Russell, Grandbois, Daniel I, Kaplan, Chen, Xu, Kathy A, Schwehr, Peter H, Santschi   +6 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

The Sorption of Technetium and Iodine Radioisotopes by Various Minerals

Nuclear Technology, 1980
Radioisotopes of technetium and iodine, elements that are present in reactor wastes, are strongly sorbed (100 ≲ KD ≲ 2000) from aqueous solutions by several naturally occurring minerals (bournonite...
R. Strickert, A. M. Friedman, S. Fried
openaire   +3 more sources

Radioisotope Therapies: Iodine-131, I-131-MIBG, and Beyond

, 2019
Radioisotopes play an integral role in the imaging and treatment of certain types of pediatric malignancies, notably differentiated thyroid cancer (DTC) and high-risk neuroblastoma. This chapter focuses on radioactive iodine (I-131) therapy of pediatric DTC and I-131-metaiodobenzylguanidine (131I-mIBG) therapy of high-risk neuroblastoma.
Neha S. Kwatra, Marguerite T. Parisi, Barry L. Shulkin   +2 more
openaire   +2 more sources